HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care

Executive Summary

In this episode of HBW Insight's Over The Counter podcast, we connect with Neil D’Souza, CEO of Makersite GmbH, a data software company based in Stuttgart, Germany that offers “next generation” product data management tools that help personal care and other industries manage product sustainability, cost and compliance.

Eighty percent of a product’s environmental impact is determined at the design phase. As laws are enacted at the federal state, and local levels to implement extended producer responsibility takeback programs, companies are pressed now more than ever to find ways to reduce packaging and incorporate bio-based packaging materials.

In this episode of HBW’s Over The Counter podcast, we connect with Neil D’Souza, CEO of Makersite GmbH, a data software company based in Stuttgart, Germany.

D’Souza spoke about the ways in which AI and other technologies are used to improve packaging design, the challenges and questions all companies face in creating a more sustainable product and opportunities in the area of reusable/refillable design.

 

 

Guest Bio

Neil D'Souza

Neil D’Souza, CEO Of Makersite GmbH, worked for 20 years in academia in the area of climate science before he committed himself to helping industry make better, more sustainable products. His firm offers digital tools that help companies manage cost, environment, compliance and risk data. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS155063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel